VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John E Leonard, PhD
Vaccinex Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Highlands Oncology Group, Pa
Fayetteville, Arkansas, United States
- University of California Los Angeles (ucla)
Los Angeles, California, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Northwell Health Cancer Institute
Lake Success, New York, United States
- University of Rochester
Rochester, New York, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- Virginia Cancer Specialists, Pc
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Oct 2017
- Primary completion
- 9 Sept 2020
- Completion
- 10 Sept 2020
- Last update posted
- 2 May 2022
- Registered enrollment
- 62
- Registry id
- NCT03268057
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.